References
1. Baddour Larry M., Bettmann Michael A., Bolger Ann F., et al. Nonvalvular Cardiovascular Device–Related Infections.Circulation . 2003;108(16):2015-2031. doi:10.1161/01.CIR.0000093201.57771.47
2. Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.Clin Microbiol Rev . 2002;15(4):716-746. doi:10.1128/cmr.15.4.716-746.2002
3. Hussein AA, Baghdy Y, Wazni OM, et al. Microbiology of Cardiac Implantable Electronic Device Infections. JACC Clin Electrophysiol . 2016;2(4):498-505. doi:10.1016/j.jacep.2016.01.019
4. Runyon EH. Conservation of the Specific Epithet fortuitum in the Name of the Organism Known as Mycobacterium fortuitum da Costa Cruz: Request for an Opinion. Int J Syst Bacteriol . 1972;22(1):50-51. doi:10.1099/00207713-22-1-50
5. Phadke VK, Hirsh DS, Goswami ND. Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation.Emerg Infect Dis . 2016;22(3):389-395. doi:10.3201/eid2203.150584
6. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med . 2007;175(4):367-416. doi:10.1164/rccm.200604-571ST
7. Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg . 2020;57(1):e1-e31. doi:10.1093/ejcts/ezz296
8. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. EP Eur . 2015;17(5):767-777. doi:10.1093/europace/euv053
9. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med . 2007;167(7):669-675. doi:10.1001/archinte.167.7.669
10. Zhu J, Yang Q, Pan J, Shi H, Jin B, Chen Q. Cardiac resynchronization therapy-defibrillator pocket infection caused by Mycobacterium fortuitum: a case report and review of the literature.BMC Cardiovasc Disord . 2019;19. doi:10.1186/s12872-019-1028-0
11. Arnold CJ, Chu VH. Cardiovascular Implantable Electronic Device Infections. Infect Dis Clin North Am . 2018;32(4):811-825. doi:10.1016/j.idc.2018.06.004
12. Devana. Pacemaker site infection caused by Rapidly Growing Nontuberculous Mycobacteria (RGM). Accessed February 6, 2020. http://www.bmbtrj.org/article.asp?issn=2588-9834;year=2018;volume=2;issue=1;spage=82;epage=84;aulast=Devana
13. Gill JS, Singh N, Khanna SP. Risk of cardiac pacemaker pocket infection in a tertiary care hospital. Indian J Pathol Microbiol . 2017;60(2):185. doi:10.4103/IJPM.IJPM_190_16
14. De Groote MA, Huitt G. Infections Due to Rapidly Growing Mycobacteria. Clin Infect Dis . 2006;42(12):1756-1763. doi:10.1086/504381
15. Wallace RJ, Meier A, Brown BA, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother . 1996;40(7):1676-1681. Accessed February 6, 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC163394/
16. Bharat V, Hittinahalli V, Mishra M, Pradhan S. Pacemaker pocket infection due to environmental mycobacteria: Successful management of an outbreak and steps for prevention in future. Indian Heart J . 2016;68(1):63-67. doi:10.1016/j.ihj.2015.06.023
Figures
Fig 1. Incision and drainage of the pocket infection